Lecturer

List of Publications dr. Janneke Alers

Signaleringsrapporten and related publications.

1.Signaleringscommissie Kanker van KWF Kankerbestrijding.

Biomarkers en kankerbestrijding: gebruik van biomarkers bij erfelijkheidsonderzoek, diagnostiek en behandeling. Amsterdam, KWF Kankerbestrijding, 2007.

2.W. van Veelen, J.Wijffels, J. Alers, L. van ‘t Veer

Biomarkers geïdentificeerd bij veelvoorkomende soorten kanker. Literatuurstudie. www.kwfkankerbestrijding.nl, 2007.


3.Signaleringscommissie Kanker van KWF Kankerbestrijding.

Advies inzake wachttijdnormen in de kankerzorg:signalement. Amsterdam, KWF Kankerbestrijding, 2006.


4.Signaleringscommissie Kanker van KWF Kankerbestrijding.

De rol van lichaamsbeweging bij de preventie van kanker. Amsterdam, KWF Kankerbestrijding, 2005.


5.Signaleringscommissie Kanker van KWF Kankerbestrijding.

Beeldvormende technieken binnen de kankerbestrijding: vizier op de toekomst. Amsterdam, KWF Kankerbestrijding, 2005.


6. Alers, JC, Pinedo, HM.

De SCK:Signaleringscommissie Kanker. Tijdschrift Kanker 2004, 22-25.


7.Signaleringscommissie Kanker van KWF Kankerbestrijding.

Kanker in Nederland: trends, prognoses en implicaties voor zorgvraag. Amsterdam, KWF Kankerbestrijding, 2004.


8. Signaleringscommissie Kanker van KWF Kankerbestrijding.

Vroege opsporing van dikkedarmkanker: minder sterfte door bevolkingsonderzoek Amsterdam, KWF Kankerbestrijding, 2004.


9. Signaleringscommissie Kanker van KWF Kankerbestrijding.

De rol van voeding bij het ontstaan van kanker. Amsterdam, KWF Kankerbestrijding, 2004.


10.Signaleringscommissie Kanker van de Nederlandse Kankerbestrijding/KWF.

Ultraviolette Straling en Huidkanker. Amsterdam, Nederlandse Kankerbestrijding/KWF, 2002.


Peer-reviewed publications

1. Postma, TJBM, Alers JC, Terpstra S, Zuurbier A.

Medical technology decisions in the Netherlands: how to solve the dilemma of technology foresight

versus market research?

Technol. Forecast. Soc. Change 2007 Nov; 74(9): 1823-33.

2. Postma TJ, Alers JC, Terpstra S, Zuurbier A.

The future of imaging techniques for cancer patients in The Netherlands : A Delphi study.

Eur J Health Econ. 2006 Jun;7(2):117-22.

3. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH,

Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH,

Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ,

Carroll PR, Rubin MA, Collins C, van Dekken H.

Whole genome scanning identifies genotypes associated with recurrence and

metastasis in prostate tumors.

Hum Mol Genet. 2004 Jul 1;13(13):1303-13.

4. van Dekken H, Paris PL, Albertson DG, Alers JC, Andaya A, Kowbel D, van der

Kwast TH, Pinkel D, Schröder FH, Vissers KJ, Wildhagen MF, Collins C.

Evaluation of genetic patterns in different tumor areas of intermediate-grade

prostatic adenocarcinomas by high-resolution genomic array analysis.

Genes Chromosomes Cancer. 2004 Mar;39(3):249-56.

5. van Dekken H, Alers JC, Damen IA, Vissers KJ, Krijtenburg PJ, Hoedemaeker RF,

Wildhagen MF, Hop WC, van der Kwast TH, Tanke HJ, Schröder FH.

Genetic evaluation of localized prostate cancer in a cohort of forty patients:

gain of distal 8q discriminates between progressors and nonprogressors.

Lab Invest. 2003 Jun;83(6):789-96.

6. van Dekken H, Wink J, Alers JC, de Man RA, IJzermans JN, Zondervan PE.

Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver

disease: a detailed analysis of two cases and a review of the literature.

Acta Histochem. 2003;105(1):29-41.

7. Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J, Jain AN,

Kamkar S, Kowbel D, Krijtenburg PJ, Pinkel D, Schröder FH, Vissers KJ, Watson VJ,

Wildhagen MF, Collins C, van Dekken H.

High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors

using comparative genomic hybridization to genomic microarrays.

Am J Pathol. 2003 Mar;162(3):763-70.

8. Kros JM, Zheng P, Dinjens WN, Alers JC.

Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.

J Neuropathol Exp Neurol. 2002 Sep;61(9):806-14.

9. Kros JM, Delwel EJ, de Jong TH, Tanghe HL, van Run PR, Vissers K, Alers JC.

Desmoplastic infantile astrocytoma and ganglioglioma: a search for genomic characteristics.

Acta Neuropathol. 2002 Aug;104(2):144-8.

10. Vissers KJ, Riegman PH, Alers JC, Tilanus HW, van Dekken H.

Involvement of cancer-activating genes on chromosomes 7 and 8 in esophageal

(Barrett's) and gastric cardia adenocarcinoma.

Anticancer Res. 2001 Nov-Dec;21(6A):3813-20.

11. Kros JM, van Run PR, Alers JC, Avezaat CJ, Luider TM, van Dekken H.

Spatial variability of genomic aberrations in a large glioblastoma resection specimen.

Acta Neuropathol. 2001 Jul;102(1):103-9.

12. van Dekken H, Alers JC, Riegman PH, Rosenberg C, Tilanus HW, Vissers K.

Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions.

Am J Pathol. 2001 Jun;158(6):1961-7.

13. de Pender AM, Alers JC, Vissers KJ, de Both NJ, Dinjens WN, van Dekken H.

Evaluation of oncogene amplification in intact and truncated cell nuclei of

gastro-esophageal cancer cell lines by DNA in situ hybridisation.

Acta Histochem. 2001 Apr;103(2):127-38.

14. Riegman PH, Vissers KJ, Alers JC, Geelen E, Hop WC, Tilanus HW, van Dekken H.

Genomic alterations in malignant transformation of Barrett's esophagus.

Cancer Res. 2001 Apr 1;61(7):3164-70.

15. Naus NC, van Drunen E, de Klein A, Luyten GP, Paridaens DA, Alers JC, Ksander

BR, Beverloo HB, Slater RM.

Characterization of complex chromosomal abnormalities in uveal melanoma by

fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.

Genes Chromosomes Cancer. 2001 Mar;30(3):267-73.

16. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WC, van

der Kwast TT, Schröder FH, Tanke HJ, van Dekken H.

Molecular cytogenetic analysis of prostatic adenocarcinomas from screening

studies : early cancers may contain aggressive genetic features.

Am J Pathol. 2001 Feb;158(2):399-406.

17. Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van

Dekken H.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular

carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

J Pathol. 2000 Oct;192(2):207-15.

18. Alers JC, Rochat J, Krijtenburg PJ, Hop WC, Kranse R, Rosenberg C, Tanke HJ,

Schröder FH, van Dekken H.

Identification of genetic markers for prostatic cancer progression.

Lab Invest. 2000 Jun;80(6):931-42.

19. van Dekken H, Krijtenburg PJ, Alers JC.

DNA in situ hybridization (interphase cytogenetics) versus comparative genomic

hybridization (CGH) in human cancer: detection of numerical and structural

chromosome aberrations.

Acta Histochem. 2000 Feb;102(1):85-94.

20. Kros JM, van Run PR, Alers JC, Beverloo HB, van den Bent MJ, Avezaat CJ, van

Dekken H.

Genetic aberrations in oligodendroglial tumours: an analysis using comparative

genomic hybridization (CGH).

J Pathol. 1999 Jul;188(3):282-8.

21. Alers JC, Rochat J, Krijtenburg PJ, van Dekken H, Raap AK, Rosenberg C.

Universal linkage system: an improved method for labeling archival DNA for

comparative genomic hybridization.

Genes Chromosomes Cancer. 1999 Jul;25(3):301-5.

22. Alers JC, Krijtenburg PJ, Vissers KJ, van Dekken H.

Effect of bone decalcification procedures on DNA in situ hybridization and

comparative genomic hybridization. EDTA is highly preferable to a routinely used

acid decalcifier.

J Histochem Cytochem. 1999 May;47(5):703-10.

23. Alers JC, Krijtenburg PJ, Hop WC, Bolle WA, Schröder FH, van der Kwast TH,

Bosman FT, van Dekken H.

Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours

that recur in time display an intermediate genetic status between non-persistent

and metastatic tumours.

J Pathol. 1998 Jul;185(3):273-83.

24. Rosso SM, van Dekken H, Krishnadath KK, Alers JC, Kros JM.

Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.

J Neuropathol Exp neurol 1997 Oct; 56(10):1125-31.

25. Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schröder FH, van

der Kwast TH, Bosman FT, van Dekken H.

Interphase cytogenetics of prostatic tumor progression: specific chromosomal

abnormalities are involved in metastasis to the bone.

Lab Invest. 1997 Nov;77(5):437-48.

26. van Dekken H, Rosenberg C, Krijtenburg PJ, Alers JC.

Interphase cytogenetics and comparative genomic hybridization of human epithelial

cancers and precursor lesions.

Histochem Cell Biol. 1997 Oct-Nov;108(4-5):419-30. Review.

27. Mesker WE, Alers JC, Sloos WC, Vrolijk H, Raap AK, Dekken HV, Tanke HJ.

Automated assessment of numerical chromosomal aberrations in paraffin embedded

prostate tumor cells stained by in situ hybridization.

Cytometry. 1996 Dec 15;26(4):298-304.

28. Krijtenburg PJ, Alers JC, Bosman FT, van Dekken H.

Comparison of automated and manual analysis of interphase in situ hybridization

signals in tissue sections and nuclear suspensions.

Cytometry. 1996 Sep 1;25(1):99-103.

29. Alers JC, van Dekken H.

Interphase cytogenetic analysis of solid tumors by non-isotopic DNA in situ hybridization.

Prog Histochem Cytochem. 1996;31(3):1-133. Review. (book).

30. Alers JC, Krijtenburg PJ, Vissers KJ, Krishnadath SK, Bosman FT, van Dekken H.

Interphase in situ hybridization to disaggregated and intact tissue specimens of

prostatic adenocarcinomas.

Histochem Cell Biol. 1995 Dec;104(6):479-86.

31. Alers JC, Krijtenburg PJ, Vissers CJ, Bosman FT, van der Kwast TH, van Dekken H.

Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic

cancer.

Cytometry. 1995 Sep 1;21(1):84-94.

32. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, van Dekken H.

Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions:

analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias.

Genes Chromosomes Cancer. 1995 Apr;12(4):241-50.

33. Krishnadath KK, Tilanus HW, Alers JC, Mulder AH, van Dekken H.

Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus

by DNA in situ hybridization and immunohistochemistry.

Cytometry. 1994 Feb 1;15(2):176-84.

34. van Gorp J, Jacobse KC, Broekhuizen R, Alers J, van den Tweel JG, de Weger RA.

Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic

cells in residual germinal centres in Hodgkin's disease.

J Clin Pathol. 1994 Jan;47(1):29-32.

35. van Dekken H, Alers J.

Loss of chromosome Y in prostatic cancer cells but not in stromal tissue.

Cancer Genet Cytogenet. 1993 Apr;66(2):131-2.